CME
CME GROUP INC.
- Latest sale
- $204k
- Nov 18 · No plan
- Form 4 sales
- 596
- On record
- Form 144 notices
- 22
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleNo planMay 18 2026
Sold 5,753 shares at $304.63 ($1.8M)
Piell Hilda Harris, Sr MD & Chief HR Officer
No 10b5-1 planSold 17.2% of holdings ($10.2M position)27,702 shares leftFiling
- 2 Form 4 saleUnusualSep 10 +115 days
Sold 15,000 shares at $274.44 ($4.1M)
Duffy Terrence A, Chairman and CEO
No 10b5-1 planSold 27% of holdings ($15.3M position)40,630 shares left0.5x usual sizeFiling
- 3 Form 4 saleNo planSep 14 +4 days
Sold 500 shares at $280.11 ($140k)
Cook Elizabeth A, Director
No 10b5-1 planSold 2.7% of holdings ($5.2M position)17,916 shares leftFiling
- 4 Form 144 noticeNoticeNov 18 +65 days
Filed to sell 655 shares ($204k)
Marchese John Clifford, Officer
No 10b5-1 planFirst sale on recordFiling
- 5 Form 144 noticeNoticeNov 18 same day
Filed to sell 4,037 shares ($1.3M)
Piell Hilda Harris, Officer
No 10b5-1 planFiling
- 6 Form 144 noticeNoticeNov 18 same day
Filed to sell 27,000 shares ($8.3M)
Duffy Terrence A, Self
No 10b5-1 plan1x usual sizeFiling
- 7 Form 4 saleUnusualNov 18 same day
Sold 27,000 shares at $309.57 ($8.4M)
Duffy Terrence A, Chairman and CEO
No 10b5-1 planSold 43.2% of holdings ($19.3M position)35,442 shares left1x usual sizeFollows a Form 144Filing
- 8 Form 4 saleNo planNov 18 same day
Sold 655 shares at $310.75 ($204k)
Marchese John Clifford, Sr MD, General Counsel
No 10b5-1 planSold 18.2% of holdings ($1.1M position)2,943 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales, notices and lockups (newest 400 of 618)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2026 | Marchese John Clifford | Sr MD, General Counsel | Form 4 sale | 655 | $204k | 18.2% | No plan | SEC |
| Nov 18, 2026 | Duffy Terrence A | Chairman and CEO | Form 4 sale | 27,000 | $8.4M | 43.2% | Unusual | SEC |
| Nov 18, 2026 | Duffy Terrence A | Self | Form 144 notice | 27,000 | $8.3M | Notice | SEC | |
| Nov 18, 2026 | Piell Hilda Harris | Officer | Form 144 notice | 4,037 | $1.3M | Notice | SEC | |
| Nov 18, 2026 | Marchese John Clifford | Officer | Form 144 notice | 655 | $204k | Notice | SEC | |
| Sep 14, 2026 | Cook Elizabeth A | Director | Form 4 sale | 500 | $140k | 2.7% | No plan | SEC |
| Sep 10, 2026 | Duffy Terrence A | Chairman and CEO | Form 4 sale | 15,000 | $4.1M | 27.0% | Unusual | SEC |
| May 18, 2026 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 5,753 | $1.8M | 17.2% | No plan | SEC |
| May 15, 2026 | Duffy Terrence A | Chairman and CEO | Form 4 sale | 35,000 | $10.4M | 38.6% | Unusual | SEC |
| Mar 17, 2026 | Marcus Jonathan L | Sr MD General Counsel | Form 4 sale | 3,291 | $1.1M | 31.4% | Unusual | SEC |
| Mar 12, 2026 | Vroman Ken | Chief Transformation Officer | Form 4 sale | 5,160 | $1.6M | 25.7% | Unusual | SEC |
| Mar 6, 2026 | Cook Elizabeth A | Director | Form 4 sale | 1,000 | $320k | 5.3% | No plan | SEC |
| Feb 23, 2026 | Durkin Bryan T | Director | Form 4 sale | 4,200 | $1.3M | 8.9% | No plan | SEC |
| Feb 20, 2026 | Gepsman Martin J | Director | Form 4 sale | 300 | $92k | 1.2% | No plan | SEC |
| Feb 6, 2026 | Suskind Dennis | Director | Form 4 sale | 748 | $224k | 21.7% | No plan | SEC |
| Dec 11, 2025 | Duffy Terrence A | Chairman and CEO | Form 4 sale | 25,000 | $6.7M | 27.5% | Unusual | SEC |
| Nov 20, 2025 | Sammann Derek | Sr MD Gl Hd Commodities Mkts | Form 4 sale | 7,200 | $2M | 50.6% | Unusual | SEC |
| Nov 3, 2025 | Ford Harold Eugene Jr. | Director | Form 4 sale | 1,000 | $264k | 47.8% | Unusual | SEC |
| Sep 18, 2025 | Marcus Jonathan L | Sr MD General Counsel | Form 4 sale | 392 | $103k | 4.8% | Routine | SEC |
| Sep 16, 2025 | Marcus Jonathan L | Sr MD General Counsel | Form 4 sale | 376 | $97k | 4.2% | Routine | SEC |
| Sep 16, 2025 | McCourt Timothy Francis | Sr MD Global Head Equity & FX | Form 4 sale | 379 | $98k | 3.8% | No plan | SEC |
| Aug 26, 2025 | Cutinho Sunil | Chief Information Officer | Form 4 sale | 11,896 | $3.2M | 40.6% | Unusual | SEC |
| Jun 10, 2025 | Carey Charles P | Director | Form 4 sale | 500 | $133k | 9.3% | No plan | SEC |
| May 22, 2025 | Kaye Daniel G | Director | Form 4 sale | 500 | $141k | 12.0% | No plan | SEC |
| May 20, 2025 | Marcus Jonathan L | Sr MD General Counsel | Form 4 sale | 390 | $108k | 5.5% | Routine | SEC |
| May 19, 2025 | Lockett Phyllis M | Director | Form 4 sale | 1,060 | $295k | 25.4% | Unusual | SEC |
| May 15, 2025 | Gepsman Martin J | Director | Form 4 sale | 300 | $82k | 1.2% | No plan | SEC |
| May 15, 2025 | Carey Charles P | Director | Form 4 sale | 3,000 | $818k | 35.7% | Unusual | SEC |
| May 5, 2025 | Sammann Derek | Sr MD Gl Hd Commodities Mkts | Form 4 sale | 4,650 | $1.3M | 35.8% | Unusual | SEC |
| Apr 29, 2025 | Suskind Dennis | Director | Form 4 sale | 1,000 | $271k | 25.5% | Unusual | SEC |
| Apr 25, 2025 | Gerdes Larry G | Director | Form 4 sale | 4,000 | $1.1M | 9.8% | No plan | SEC |
| Mar 14, 2025 | Lucas Deborah J | Director | Form 4 sale | 1,500 | $385k | 30.9% | Unusual | SEC |
| Mar 13, 2025 | Siegel Howard J | Director | Form 4 sale | 10,000 | $2.6M | 31.4% | Unusual | SEC |
| Mar 11, 2025 | Duffy Terrence A | Chairman and CEO | Form 4 sale | 30,000 | $7.8M | 36.1% | Unusual | SEC |
| Mar 3, 2025 | Sprague Suzanne | COO & Global Head of Clearing | Form 4 sale | 1,500 | $385k | 15.7% | No plan | SEC |
| Feb 27, 2025 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 3,984 | $998k | 12.8% | No plan | SEC |
| Feb 13, 2025 | Vroman Ken | Chief Transformation Officer | Form 4 sale | 5,066 | $1.3M | 23.3% | No plan | SEC |
| Feb 13, 2025 | Winkler Julie | Sr MD Chief Commercial Officer | Form 4 sale | 11,592 | $2.9M | 34.6% | Unusual | SEC |
| Nov 12, 2024 | Cook Elizabeth A | Director | Form 4 sale | 750 | $170k | 3.9% | No plan | SEC |
| Nov 4, 2024 | Gepsman Martin J | Director | Form 4 sale | 400 | $89k | 1.6% | No plan | SEC |
| Oct 30, 2024 | Cutinho Sunil | Chief Information Officer | Form 4 sale | 4,500 | $1M | 14.3% | No plan | SEC |
| Oct 30, 2024 | Bitsberger Timothy S. | Director | Form 4 sale | 1,000 | $227k | 8.6% | No plan | SEC |
| Oct 28, 2024 | McCourt Timothy Francis | Sr MD Global Head Equity & FX | Form 4 sale | 1,374 | $312k | 15.9% | Unusual | SEC |
| Sep 15, 2024 | Fitzpatrick Lynne | Sr MD Chief Financial Officer | Form 4 sale | 754 | $164k | 5.4% | No plan | SEC |
| Aug 30, 2024 | Durkin Bryan T | Director | Form 4 sale | 7,593 | $1.6M | 12.0% | No plan | SEC |
| Jun 13, 2024 | Carey Charles P | Director | Form 4 sale | 3,000 | $586k | 29.5% | Unusual | SEC |
| Jun 6, 2024 | Glickman Daniel R | Director | Form 4 sale | 650 | $131k | 4.4% | No plan | SEC |
| May 20, 2024 | Cook Elizabeth A | Director | Form 4 sale | 1,000 | $212k | 5.2% | No plan | SEC |
| May 13, 2024 | Savage Terry L | Director | Form 4 sale | 2,500 | $527k | 12.5% | No plan | SEC |
| May 8, 2024 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 7,140 | $1.5M | 19.6% | No plan | SEC |
| Apr 29, 2024 | Duffy Terrence A | Chairman and CEO | Form 4 sale | 40,000 | $8.4M | 37.2% | Unusual | SEC |
| Jan 31, 2024 | McCourt Timothy Francis | Sr MD Global Head Equity & FX | Form 4 sale | 35 | $7k | 0.5% | No plan | SEC |
| Dec 11, 2023 | Durkin Bryan T | Director | Form 4 sale | 5,560 | $1.2M | 8.2% | No plan | SEC |
| Dec 4, 2023 | Sammann Derek | Sr MD Gl Hd Commodity & Option | Form 4 sale | 12,543 | $2.8M | 100.0% | Unusual | SEC |
| Dec 1, 2023 | Sammann Derek | Officer | Form 144 notice | 931 | $204k | Notice | SEC | |
| Dec 1, 2023 | Sammann Derek | Officer | Form 144 notice | 931 | $204k | Notice | SEC | |
| Dec 1, 2023 | Sammann Derek | Officer | Form 144 notice | 931 | $206k | Notice | SEC | |
| Dec 1, 2023 | Sammann Derek | Officer | Form 144 notice | 9,750 | $2.1M | Notice | SEC | |
| Nov 6, 2023 | Suskind Dennis | Director | Form 4 sale | 1,500 | $320k | 32.1% | Unusual | SEC |
| Nov 6, 2023 | Suskind Dennis | Affiliate | Form 144 notice | 1,500 | $320k | Notice | SEC | |
| Oct 31, 2023 | McCourt Timothy Francis | Sr MD Global Head Equity & FX | Form 4 sale | 43 | $9k | 0.7% | No plan | SEC |
| Oct 31, 2023 | Sprague Suzanne | Sr MD Global Head of Clearing | Form 4 sale | 1,146 | $243k | 14.1% | No plan | SEC |
| Oct 31, 2023 | McCourt Timothy Francis | Officer | Form 144 notice | 43 | $9k | Notice | SEC | |
| Oct 30, 2023 | Cook Elizabeth A | Director | Form 4 sale | 500 | $106k | 2.5% | No plan | SEC |
| Oct 27, 2023 | Cook Elizabeth A | Director | Form 4 sale | 500 | $104k | 2.5% | No plan | SEC |
| Oct 27, 2023 | Cook Elizabeth A | Director | Form 144 notice | 1,000 | $215k | Notice | SEC | |
| Oct 27, 2023 | Sprague Suzanne | Officer | Form 144 notice | 1,163 | $250k | Notice | SEC | |
| Oct 26, 2023 | McCourt Timothy Francis | Sr MD Global Head Equity & FX | Form 4 sale | 1,043 | $226k | 14.1% | No plan | SEC |
| Oct 26, 2023 | McCourt Timothy Francis | Officer | Form 144 notice | 1,043 | $226k | Notice | SEC | |
| Oct 26, 2023 | Gepsman Martin J | Director | Form 4 sale | 300 | $65k | 1.2% | No plan | SEC |
| Oct 26, 2023 | Gepsman Martin J | Director | Form 144 notice | 300 | $65k | Notice | SEC | |
| Aug 18, 2023 | Duffy Terrence A | Chairman and CEO | Form 4 sale | 30,000 | $6.1M | 31.4% | Unusual | SEC |
| Aug 18, 2023 | Duffy Terrence A | Officer | Form 144 notice | 30,000 | $6.1M | Notice | SEC | |
| Aug 15, 2023 | Holzrichter Julie | Officer | Form 144 notice | 6,000 | $1.2M | Notice | SEC | |
| Aug 15, 2023 | Holzrichter Julie | Sr MD Chief Operating Officer | Form 4 sale | 6,000 | $1.2M | 15.8% | No plan | SEC |
| Aug 11, 2023 | Bitsberger Timothy S. | Director | Form 4 sale | 800 | $165k | 6.9% | No plan | SEC |
| Aug 11, 2023 | Bitsberger Timothy S. | Officer | Form 144 notice | 800 | $165k | Notice | SEC | |
| Aug 10, 2023 | Winkler Julie | Sr MD Chief Commercial Officer | Form 4 sale | 6,262 | $1.3M | 19.8% | No plan | SEC |
| Aug 10, 2023 | Winkler Julie | Officer | Form 144 notice | 6,262 | $1.3M | Notice | SEC | |
| Aug 9, 2023 | Glickman Daniel R | Director | Form 4 sale | 750 | $155k | 4.9% | No plan | SEC |
| Aug 9, 2023 | Glickman Daniel R | Director | Form 144 notice | 750 | $155k | Notice | SEC | |
| Aug 7, 2023 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 4,477 | $931k | 12.7% | No plan | SEC |
| Aug 7, 2023 | Piell Hilda Harris | Officer | Form 144 notice | 4,477 | $931k | Notice | SEC | |
| Jul 28, 2023 | Cutinho Sunil | Executive Officer, Chief Information Officer | Form 144 notice | 9,328 | $1.9M | Notice | SEC | |
| Jul 28, 2023 | Tully Sean | Officer | Form 144 notice | 5,000 | $1M | Notice | SEC | |
| Jul 28, 2023 | Cutinho Sunil | Chief Information Officer | Form 4 sale | 19,430 | $3.9M | 45.6% | Unusual | SEC |
| Jul 27, 2023 | Cutinho Sunil | Officer | Form 144 notice | 10,102 | $2M | Notice | SEC | |
| Sep 20, 2022 | McCourt Timothy Francis | Sr MD Global Head Equity & FX | Form 4 sale | 97 | $18k | 1.8% | Plan not stated | SEC |
| Sep 19, 2022 | McCourt Timothy Francis | Sr MD Global Head Equity & FX | Form 4 sale | 360 | $69k | 6.2% | Plan not stated | SEC |
| Sep 12, 2022 | Vroman Ken | Chief Transformation Officer | Form 4 sale | 750 | $151k | 5.7% | Plan not stated | SEC |
| Sep 9, 2022 | Sammann Derek | Sr MD Gl Hd Commodity & Option | Form 4 sale | 4,000 | $806k | 23.1% | Plan not stated | SEC |
| Aug 31, 2022 | Glickman Daniel R | Director | Form 4 sale | 500 | $98k | 3.3% | Plan not stated | SEC |
| Aug 15, 2022 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 4,901 | $999k | 12.9% | Plan not stated | SEC |
| Mar 14, 2022 | Tully Sean | Sr MD Global Hd Financial & OT | Form 4 sale | 4,000 | $919k | 18.2% | Plan not stated | SEC |
| Mar 11, 2022 | Cronin Kathleen M | Sr MD Gen Counsel & Corp Secr | Form 4 sale | 4,000 | $909k | 9.0% | Plan not stated | SEC |
| Mar 11, 2022 | Tully Sean | Sr MD Global Hd Financial & OT | Form 4 sale | 3,000 | $687k | 12.0% | Plan not stated | SEC |
| Mar 3, 2022 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 2,000 | $488k | 5.2% | Plan not stated | SEC |
| Mar 1, 2022 | Glickman Daniel R | Director | Form 4 sale | 750 | $176k | 5.0% | Plan not stated | SEC |
| Feb 24, 2022 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 1,500 | $351k | 3.8% | Plan not stated | SEC |
| Feb 14, 2022 | Cutinho Sunil | Sr MD & President CME Clearing | Form 4 sale | 4,900 | $1.2M | 11.3% | Plan not stated | SEC |
| Feb 10, 2022 | Carey Charles P | Director | Form 4 sale | 3,000 | $733k | 28.1% | Unusual | SEC |
| Feb 10, 2022 | Cook Elizabeth A | Director | Form 4 sale | 1,000 | $244k | 5.1% | Plan not stated | SEC |
| Feb 10, 2022 | Kometer Kevin | Sr MD Chief Information Office | Form 4 sale | 13,500 | $3.3M | 17.6% | Plan not stated | SEC |
| Dec 7, 2021 | Gepsman Martin J | Director | Form 4 sale | 500 | $116k | 2.1% | Plan not stated | SEC |
| Dec 2, 2021 | Sammann Derek | Sr MD Gl Hd Commodity & Option | Form 4 sale | 4,500 | $1M | 28.3% | Unusual | SEC |
| Nov 12, 2021 | Siegel Howard J | Director | Form 4 sale | 6,000 | $1.3M | 7.4% | Plan not stated | SEC |
| Nov 11, 2021 | Holzrichter Julie | Sr MD Chief Operating Officer | Form 4 sale | 5,000 | $1.1M | 12.9% | Plan not stated | SEC |
| Nov 10, 2021 | Bitsberger Timothy S. | Director | Form 4 sale | 600 | $133k | 5.6% | Plan not stated | SEC |
| Nov 9, 2021 | Vroman Ken | Sr MD International & Optimiza | Form 4 sale | 445 | $98k | 3.3% | Plan not stated | SEC |
| Nov 5, 2021 | Durkin Bryan T | Director | Form 4 sale | 10,000 | $2.2M | 12.8% | Plan not stated | SEC |
| Oct 28, 2021 | Gepsman Martin J | Director | Form 4 sale | 500 | $109k | 2.0% | Plan not stated | SEC |
| Oct 19, 2021 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 2,947 | $634k | 6.9% | Plan not stated | SEC |
| Sep 13, 2021 | Gepsman Martin J | Director | Form 4 sale | 1,000 | $189k | 3.9% | Plan not stated | SEC |
| Sep 7, 2021 | Gepsman Martin J | Director | Form 4 sale | 1,000 | $194k | 3.8% | Plan not stated | SEC |
| Aug 30, 2021 | Gepsman Martin J | Director | Form 4 sale | 1,000 | $201k | 3.6% | Plan not stated | SEC |
| Aug 24, 2021 | Tully Sean | Sr MD Global Hd Financial & OT | Form 4 sale | 5,000 | $1M | 17.6% | Plan not stated | SEC |
| Aug 23, 2021 | Gepsman Martin J | Director | Form 4 sale | 1,000 | $201k | 3.5% | Plan not stated | SEC |
| Jun 14, 2021 | Siegel Howard J | Director | Form 4 sale | 1,500 | $323k | 1.8% | Plan not stated | SEC |
| Jun 14, 2021 | Cronin Kathleen M | Sr MD Gen Counsel & Corp Secr | Form 4 sale | 4,092 | $881k | 8.8% | Plan not stated | SEC |
| Jun 9, 2021 | Cook Elizabeth A | Director | Form 4 sale | 2,000 | $432k | 9.0% | Plan not stated | SEC |
| May 27, 2021 | Winkler Julie | Sr MD Chief Commercial Officer | Form 4 sale | 3,500 | $760k | 12.1% | Plan not stated | SEC |
| May 19, 2021 | Duffy Terrence A | Chairman and CEO | Form 4 sale | 29,000 | $6.1M | 34.3% | Unusual | SEC |
| May 12, 2021 | Holzrichter Julie | Sr MD Chief Operating Officer | Form 4 sale | 6,000 | $1.3M | 14.1% | Plan not stated | SEC |
| Mar 11, 2021 | Gepsman Martin J | Director | Form 4 sale | 1,500 | $308k | 5.1% | Plan not stated | SEC |
| Mar 5, 2021 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 1,500 | $320k | 3.9% | Plan not stated | SEC |
| Feb 26, 2021 | Sammann Derek | Sr MD Gl Hd Commodity & Option | Form 4 sale | 7,335 | $1.5M | 29.4% | Unusual | SEC |
| Feb 26, 2021 | Tully Sean | Sr MD Global Hd Financial & OT | Form 4 sale | 10,000 | $2M | 33.7% | Unusual | SEC |
| Feb 19, 2021 | Durkin Bryan T | Director | Form 4 sale | 11,000 | $2.2M | 13.4% | Plan not stated | SEC |
| Feb 19, 2021 | Kometer Kevin | Sr MD Chief Information Office | Form 4 sale | 8,000 | $1.6M | 10.3% | Plan not stated | SEC |
| Feb 12, 2021 | Suskind Dennis | Director | Form 4 sale | 1,000 | $183k | 28.1% | Unusual | SEC |
| Jan 7, 2021 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 1,500 | $297k | 3.8% | Plan not stated | SEC |
| Dec 21, 2020 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 2,300 | $419k | 5.5% | Plan not stated | SEC |
| Dec 14, 2020 | Gepsman Martin J | Director | Form 4 sale | 400 | $71k | 1.3% | Plan not stated | SEC |
| Dec 14, 2020 | Winkler Julie | Sr MD Chief Commercial Officer | Form 4 sale | 4,059 | $735k | 14.0% | Plan not stated | SEC |
| Dec 14, 2020 | Cronin Kathleen M | Sr MD Gen Counsel & Corp Secr | Form 4 sale | 6,208 | $1.1M | 12.6% | Plan not stated | SEC |
| Dec 1, 2020 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 5,000 | $900k | 10.6% | Plan not stated | SEC |
| Dec 1, 2020 | Holzrichter Julie | Sr MD Chief Operating Officer | Form 4 sale | 3,188 | $574k | 7.8% | Plan not stated | SEC |
| Dec 1, 2020 | Gepsman Martin J | Director | Form 4 sale | 800 | $143k | 2.6% | Plan not stated | SEC |
| Nov 2, 2020 | Vroman Ken | Sr MD International & Optimiza | Form 4 sale | 4,541 | $693k | 31.5% | Unusual | SEC |
| Sep 2, 2020 | Gepsman Martin J | Director | Form 4 sale | 5,000 | $868k | 14.0% | Plan not stated | SEC |
| Aug 27, 2020 | Cutinho Sunil | Sr MD & President CME Clearing | Form 4 sale | 5,600 | $997k | 14.2% | Plan not stated | SEC |
| Aug 25, 2020 | Suskind Dennis | Director | Form 4 sale | 2,000 | $349k | 35.9% | Unusual | SEC |
| Aug 17, 2020 | Glickman Daniel R | Director | Form 4 sale | 900 | $156k | 5.9% | Plan not stated | SEC |
| Aug 11, 2020 | Carey Charles P | Director | Form 4 sale | 8,000 | $1.3M | 56.6% | Unusual | SEC |
| Jun 8, 2020 | Bitsberger Timothy S. | Director | Form 4 sale | 600 | $115k | 6.0% | Plan not stated | SEC |
| Jun 5, 2020 | Holzrichter Julie | Sr MD Chief Operating Officer | Form 4 sale | 3,090 | $588k | 7.5% | Plan not stated | SEC |
| May 21, 2020 | Durkin Bryan T | Director | Form 4 sale | 9,000 | $1.6M | 9.9% | Plan not stated | SEC |
| Apr 6, 2020 | Holzrichter Julie | Sr MD Chief Operating Officer | Form 4 sale | 3,011 | $542k | 6.8% | Plan not stated | SEC |
| Feb 28, 2020 | Holzrichter Julie | Sr MD Chief Operating Officer | Form 4 sale | 3,061 | $623k | 7.6% | Plan not stated | SEC |
| Feb 24, 2020 | Winkler Julie | Sr MD Chief Commercial Officer | Form 4 sale | 5,620 | $1.2M | 20.1% | Plan not stated | SEC |
| Jan 3, 2020 | Gepsman Martin J | Director | Form 4 sale | 1,000 | $201k | 2.8% | Plan not stated | SEC |
| Dec 13, 2019 | Cronin Kathleen M | Sr MD Gen Counsel & Corp Secr | Form 4 sale | 3,371 | $688k | 7.5% | Plan not stated | SEC |
| Dec 12, 2019 | Duffy Terrence A | Chairman and CEO | Form 4 sale | 39,309 | $8M | 45.7% | Unusual | SEC |
| Nov 7, 2019 | Pankau Ronald A. | Director | Form 4 sale | 300 | $60k | 7.1% | Plan not stated | SEC |
| Sep 6, 2019 | Tully Sean | Sr MD Global Hd Financial & OT | Form 4 sale | 7,200 | $1.6M | 26.5% | Unusual | SEC |
| Sep 4, 2019 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 2,500 | $544k | 7.6% | Plan not stated | SEC |
| Sep 3, 2019 | Holzrichter Julie | Sr MD Chief Operating Officer | Form 4 sale | 3,436 | $742k | 8.2% | Plan not stated | SEC |
| Aug 28, 2019 | Glickman Daniel R | Director | Form 4 sale | 500 | $108k | 3.3% | Plan not stated | SEC |
| Aug 9, 2019 | Suskind Dennis | Director | Form 4 sale | 1,500 | $319k | 23.6% | Plan not stated | SEC |
| Aug 6, 2019 | Cutinho Sunil | Sr MD & President CME Clearing | Form 4 sale | 1,990 | $403k | 6.0% | Plan not stated | SEC |
| Aug 2, 2019 | Siegel Howard J | Director | Form 4 sale | 5,000 | $1M | 5.9% | Plan not stated | SEC |
| Aug 1, 2019 | Duffy Terrence A | Chairman & CEO | Form 4 sale | 35,000 | $7M | 30.7% | Unusual | SEC |
| Jul 9, 2019 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 2,500 | $503k | 7.1% | Plan not stated | SEC |
| Jun 12, 2019 | Sammann Derek | Sr MD Gl Hd Commodity & Option | Form 4 sale | 6,400 | $1.3M | 57.4% | Unusual | SEC |
| Jun 12, 2019 | Winkler Julie | Sr MD Chief Commercial Officer | Form 4 sale | 4,767 | $944k | 18.9% | Plan not stated | SEC |
| Jun 10, 2019 | Cook Elizabeth A | Director | Form 4 sale | 300 | $61k | 1.4% | Plan not stated | SEC |
| Jun 7, 2019 | Kometer Kevin | Sr MD Chief Information Office | Form 4 sale | 16,140 | $3.2M | 19.6% | Plan not stated | SEC |
| Jun 6, 2019 | Pankau Ronald A. | Director | Form 4 sale | 200 | $40k | 5.6% | Plan not stated | SEC |
| Jun 6, 2019 | Gepsman Martin J | Director | Form 4 sale | 2,500 | $503k | 6.6% | Unusual | SEC |
| Jun 5, 2019 | Cook Elizabeth A | Director | Form 4 sale | 500 | $100k | 2.3% | Plan not stated | SEC |
| Jun 4, 2019 | Bitsberger Timothy S. | Director | Form 4 sale | 700 | $136k | 6.9% | Plan not stated | SEC |
| Jun 3, 2019 | Holzrichter Julie | Sr MD Chief Operating Officer | Form 4 sale | 4,241 | $815k | 9.1% | Plan not stated | SEC |
| May 24, 2019 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 1,132 | $213k | 3.3% | Plan not stated | SEC |
| May 22, 2019 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 1,420 | $264k | 4.0% | Plan not stated | SEC |
| May 21, 2019 | Cronin Kathleen M | Sr MD Gen Counsel & Corp Secr | Form 4 sale | 4,960 | $926k | 10.1% | Plan not stated | SEC |
| May 8, 2019 | Carey Charles P | Director | Form 4 sale | 10,000 | $1.8M | 41.4% | Unusual | SEC |
| May 7, 2019 | Gepsman Martin J | Director | Form 4 sale | 2,000 | $356k | 5.0% | Unusual | SEC |
| Apr 3, 2019 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 2,500 | $421k | 6.6% | Plan not stated | SEC |
| Mar 14, 2019 | Gepsman Martin J | Director | Form 4 sale | 3,000 | $504k | 7.0% | Unusual | SEC |
| Mar 14, 2019 | Cronin Kathleen M | Sr MD Gen Counsel & Corp Secr | Form 4 sale | 8,340 | $1.4M | 17.2% | Plan not stated | SEC |
| Mar 1, 2019 | Holzrichter Julie | Sr MD Chief Operating Officer | Form 4 sale | 4,362 | $796k | 9.6% | Plan not stated | SEC |
| Mar 1, 2019 | Pankau Ronald A. | Director | Form 4 sale | 200 | $37k | 5.3% | Plan not stated | SEC |
| Feb 26, 2019 | Bernacchi Jeffrey M. | Director | Form 4 sale | 10,087 | $1.8M | 19.4% | Plan not stated | SEC |
| Jan 2, 2019 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 17,960 | $3.4M | 35.4% | Unusual | SEC |
| Dec 12, 2018 | Tully Sean | Sr MD Global Hd Financial & OT | Form 4 sale | 13,500 | $2.6M | 36.7% | Unusual | SEC |
| Dec 10, 2018 | Pankau Ronald A. | Director | Form 4 sale | 187 | $36k | 4.7% | Plan not stated | SEC |
| Nov 23, 2018 | Duffy Terrence A | Chairman and CEO | Form 4 sale | 10,000 | $1.9M | 9.5% | Plan not stated | SEC |
| Nov 21, 2018 | Carey Charles P | Director | Form 4 sale | 5,000 | $959k | 17.2% | Plan not stated | SEC |
| Nov 16, 2018 | Winkler Julie | Sr MD Chief Commercial Officer | Form 4 sale | 5,847 | $1.1M | 22.9% | Plan not stated | SEC |
| Nov 6, 2018 | Holzrichter Julie | Sr MD Chief Operating Officer | Form 4 sale | 3,353 | $626k | 6.8% | Plan not stated | SEC |
| Nov 2, 2018 | Carey Charles P | Director | Form 4 sale | 2,800 | $514k | 64.6% | Unusual | SEC |
| Oct 11, 2018 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 2,500 | $450k | 7.1% | Plan not stated | SEC |
| Sep 13, 2018 | Gepsman Martin J | Director | Form 4 sale | 300 | $52k | 0.7% | Plan not stated | SEC |
| Sep 5, 2018 | Tobin Jack J | MD Chief Accounting Officer | Form 4 sale | 7,820 | $1.4M | 33.2% | Unusual | SEC |
| Sep 4, 2018 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 1,823 | $319k | 5.7% | Plan not stated | SEC |
| Sep 4, 2018 | Bernacchi Jeffrey M. | Director | Form 4 sale | 4,976 | $879k | 8.7% | Plan not stated | SEC |
| Aug 9, 2018 | Pankau Ronald A. | Director | Form 4 sale | 260 | $42k | 6.3% | Plan not stated | SEC |
| Aug 6, 2018 | Durkin Bryan T | President | Form 4 sale | 11,509 | $1.9M | 15.1% | Plan not stated | SEC |
| Jul 10, 2018 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 2,500 | $410k | 7.2% | Plan not stated | SEC |
| Jun 7, 2018 | Pankau Ronald A. | Director | Form 4 sale | 250 | $43k | 6.6% | Plan not stated | SEC |
| Jun 5, 2018 | Bitsberger Timothy S. | Director | Form 4 sale | 400 | $68k | 4.1% | Plan not stated | SEC |
| May 31, 2018 | Cronin Kathleen M | Sr MD Gen Counsel & Corp Secr | Form 4 sale | 5,320 | $876k | 12.1% | Plan not stated | SEC |
| May 25, 2018 | Gepsman Martin J | Director | Form 4 sale | 600 | $96k | 1.4% | Plan not stated | SEC |
| May 22, 2018 | Duffy Terrence A | Chairman and CEO | Form 4 sale | 20,000 | $3.2M | 17.4% | Plan not stated | SEC |
| May 22, 2018 | Bernacchi Jeffrey M. | Director | Form 4 sale | 3,815 | $614k | 6.3% | Plan not stated | SEC |
| Apr 10, 2018 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 2,500 | $403k | 6.7% | Plan not stated | SEC |
| Feb 20, 2018 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 3,299 | $539k | 10.9% | Plan not stated | SEC |
| Feb 15, 2018 | Gepsman Martin J | Director | Form 4 sale | 300 | $49k | 0.7% | Plan not stated | SEC |
| Feb 14, 2018 | Pankau Ronald A. | Director | Form 4 sale | 200 | $32k | 5.0% | Plan not stated | SEC |
| Feb 6, 2018 | Duffy Terrence A | Chairman and CEO | Form 4 sale | 20,000 | $3M | 16.8% | Plan not stated | SEC |
| Feb 5, 2018 | Melamed Leo | Director | Form 4 sale | 7,300 | $1.1M | 40.9% | Unusual | SEC |
| Feb 2, 2018 | Kometer Kevin | Sr MD Chief Information Office | Form 4 sale | 16,105 | $2.6M | 23.0% | Unusual | SEC |
| Feb 2, 2018 | Sammann Derek | Sr MD Gl Hd Commodity & Option | Form 4 sale | 2,400 | $388k | 6.0% | Plan not stated | SEC |
| Jan 9, 2018 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 7,500 | $1.1M | 18.8% | Plan not stated | SEC |
| Dec 18, 2017 | Tobin Jack J | MD Chief Accounting Officer | Form 4 sale | 2,325 | $354k | 13.2% | Plan not stated | SEC |
| Dec 7, 2017 | Winkler Julie | Sr MD Chief Commercial Officer | Form 4 sale | 2,457 | $370k | 13.1% | Plan not stated | SEC |
| Nov 30, 2017 | Taylor Kimberly S | Former Sr MD&Pres.Clr&PostTrad | Form 4 sale | 8,125 | $1.2M | 6.7% | Unusual | SEC |
| Nov 30, 2017 | Bernacchi Jeffrey M. | Director | Form 4 sale | 1,501 | $225k | 2.4% | Plan not stated | SEC |
| Nov 28, 2017 | Holzrichter Julie | Sr MD Chief Operating Officer | Form 4 sale | 12,920 | $1.9M | 24.0% | Unusual | SEC |
| Nov 17, 2017 | Cutinho Sunil | Sr MD & President CME Clearing | Form 4 sale | 2,600 | $363k | 10.4% | Plan not stated | SEC |
| Nov 2, 2017 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 5,175 | $723k | 11.5% | Plan not stated | SEC |
| Oct 11, 2017 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 2,500 | $342k | 5.9% | Plan not stated | SEC |
| Oct 5, 2017 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 1,350 | $186k | 4.3% | Plan not stated | SEC |
| Sep 11, 2017 | Suskind Dennis | Director | Form 4 sale | 750 | $97k | 12.9% | Plan not stated | SEC |
| Sep 6, 2017 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 714 | $92k | 2.4% | Plan not stated | SEC |
| Aug 28, 2017 | Glickman Daniel R | Director | Form 4 sale | 850 | $108k | 5.8% | Plan not stated | SEC |
| Aug 9, 2017 | Gepsman Martin J | Director | Form 4 sale | 200 | $25k | 0.5% | Plan not stated | SEC |
| Aug 8, 2017 | Durkin Bryan T | President | Form 4 sale | 9,200 | $1.2M | 13.0% | Plan not stated | SEC |
| Aug 7, 2017 | Holzrichter Julie | Sr MD Chief Operating Officer | Form 4 sale | 11,915 | $1.5M | 24.0% | Unusual | SEC |
| Aug 3, 2017 | Pankau Ronald A. | Director | Form 4 sale | 300 | $37k | 7.0% | Plan not stated | SEC |
| Aug 2, 2017 | Duffy Terrence A | Chairman and CEO | Form 4 sale | 21,815 | $2.7M | 16.5% | Plan not stated | SEC |
| Jul 10, 2017 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 2,500 | $311k | 6.1% | Plan not stated | SEC |
| Jun 14, 2017 | Cronin Kathleen M | Sr MD Gen Counsel & Corp Secr | Form 4 sale | 8,125 | $1M | 20.5% | Plan not stated | SEC |
| Jun 13, 2017 | Taylor Kimberly S | Sr MD&Pres Clearing Post-Trade | Form 4 sale | 7,400 | $932k | 6.4% | Unusual | SEC |
| Jun 13, 2017 | Bitsberger Timothy S. | Director | Form 4 sale | 800 | $101k | 8.1% | Plan not stated | SEC |
| Jun 12, 2017 | Winkler Julie | Sr MD Chief Commercial Officer | Form 4 sale | 4,315 | $539k | 21.9% | Plan not stated | SEC |
| Jun 9, 2017 | Kometer Kevin | Sr MD Chief InformationOfficer | Form 4 sale | 4,125 | $505k | 7.5% | Plan not stated | SEC |
| Jun 7, 2017 | Sammann Derek | Sr MD Gl Hd Comm &Options Prod | Form 4 sale | 2,100 | $248k | 5.7% | Plan not stated | SEC |
| Jun 7, 2017 | Holzrichter Julie | Sr MD Chief Operating Officer | Form 4 sale | 5,925 | $701k | 13.6% | Plan not stated | SEC |
| Jun 5, 2017 | Sammann Derek | Sr MD Gl Hd Comm &Options Prod | Form 4 sale | 2,100 | $248k | 5.7% | Plan not stated | SEC |
| May 24, 2017 | Cutinho Sunil | Sr MD & President CME Clearing | Form 4 sale | 10,265 | $1.2M | 32.1% | Unusual | SEC |
| Apr 28, 2017 | Suskind Dennis | Director | Form 4 sale | 1,099 | $127k | 18.0% | Plan not stated | SEC |
| Apr 10, 2017 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 2,500 | $295k | 5.7% | Plan not stated | SEC |
| Mar 14, 2017 | Cronin Kathleen M | Sr MD Gen Counsel & Corp Secr | Form 4 sale | 5,900 | $733k | 17.4% | Plan not stated | SEC |
| Mar 14, 2017 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 3,043 | $378k | 10.4% | Plan not stated | SEC |
| Feb 28, 2017 | Holzrichter Julie | Sr MD Chief Operating Officer | Form 4 sale | 600 | $73k | 1.7% | Plan not stated | SEC |
| Feb 24, 2017 | Winkler Julie | Sr MD Chief Commercial Officer | Form 4 sale | 5,888 | $721k | 30.4% | Unusual | SEC |
| Feb 24, 2017 | Pankau Ronald A. | Director | Form 4 sale | 500 | $61k | 12.5% | Plan not stated | SEC |
| Feb 3, 2017 | Suskind Dennis | Director | Form 4 sale | 1,000 | $121k | 14.1% | Plan not stated | SEC |
| Jan 9, 2017 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 7,500 | $876k | 15.9% | Unusual | SEC |
| Jan 3, 2017 | Tobin Jack J | MD Chief Accounting Officer | Form 4 sale | 1,525 | $177k | 10.2% | Plan not stated | SEC |
| Dec 29, 2016 | Taylor Kimberly S | Pres Clr & Post Trade Srvcs | Form 4 sale | 1,351 | $157k | 1.3% | Plan not stated | SEC |
| Dec 28, 2016 | Durkin Bryan T | President | Form 4 sale | 14,886 | $1.7M | 21.7% | Plan not stated | SEC |
| Dec 12, 2016 | Pankau Ronald A. | Director | Form 4 sale | 382 | $47k | 8.7% | Plan not stated | SEC |
| Dec 12, 2016 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 4,625 | $570k | 8.9% | Unusual | SEC |
| Dec 9, 2016 | Suskind Dennis | Director | Form 4 sale | 1,000 | $122k | 12.3% | Plan not stated | SEC |
| Dec 8, 2016 | Duffy Terrence A | Chairman & CEO | Form 4 sale | 27,550 | $3.3M | 20.0% | Plan not stated | SEC |
| Dec 7, 2016 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 5,850 | $702k | 16.7% | Unusual | SEC |
| Nov 30, 2016 | Taylor Kimberly S | Sr MD Pres Gl Ops Tech & Risk | Form 4 sale | 2,300 | $260k | 2.2% | Plan not stated | SEC |
| Nov 30, 2016 | Durkin Bryan T | President | Form 4 sale | 15,000 | $1.7M | 21.8% | Plan not stated | SEC |
| Nov 25, 2016 | Duffy Terrence A | Chairman & CEO | Form 4 sale | 17,375 | $2M | 13.6% | Plan not stated | SEC |
| Nov 2, 2016 | Suskind Dennis | Director | Form 4 sale | 2,000 | $201k | 19.8% | Plan not stated | SEC |
| Oct 31, 2016 | Taylor Kimberly S | Sr MD Pres Gl Ops Tech & Risk | Form 4 sale | 2,300 | $230k | 2.2% | Plan not stated | SEC |
| Oct 31, 2016 | Durkin Bryan T | Sr MD Chief Commercial Officer | Form 4 sale | 15,000 | $1.5M | 21.8% | Plan not stated | SEC |
| Oct 3, 2016 | Tobin Jack J | MD Chief Accounting Officer | Form 4 sale | 3,750 | $390k | 21.7% | Plan not stated | SEC |
| Sep 29, 2016 | Taylor Kimberly S | Sr MD Pres Gl Ops Tech & Risk | Form 4 sale | 2,300 | $244k | 2.1% | Plan not stated | SEC |
| Sep 28, 2016 | Durkin Bryan T | Sr MD Chief Commercial Officer | Form 4 sale | 14,990 | $1.6M | 21.8% | Plan not stated | SEC |
| Sep 19, 2016 | Gill Phupinder | CEO | Form 4 sale | 30,002 | $3.3M | 20.5% | Plan not stated | SEC |
| Sep 19, 2016 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 893 | $98k | 3.0% | Plan not stated | SEC |
| Sep 13, 2016 | Bitsberger Timothy S. | Director | Form 4 sale | 700 | $75k | 6.7% | Plan not stated | SEC |
| Sep 13, 2016 | Bernacchi Jeffrey M. | Director | Form 4 sale | 5,187 | $559k | 7.9% | Plan not stated | SEC |
| Sep 6, 2016 | Durkin Bryan T | Sr MD Chief Commercial Officer | Form 4 sale | 15,000 | $1.6M | 23.4% | Plan not stated | SEC |
| Sep 2, 2016 | Gepsman Martin J | Director | Form 4 sale | 300 | $33k | 0.7% | Plan not stated | SEC |
| Sep 1, 2016 | Suskind Dennis | Director | Form 4 sale | 1,000 | $109k | 9.0% | Plan not stated | SEC |
| Aug 30, 2016 | Taylor Kimberly S | Sr MD Pres Gl Ops Tech & Risk | Form 4 sale | 2,300 | $246k | 2.2% | Plan not stated | SEC |
| Aug 15, 2016 | Gill Phupinder | CEO | Form 4 sale | 20,080 | $2.1M | 13.0% | Plan not stated | SEC |
| Aug 11, 2016 | Pankau Ronald A. | Director | Form 4 sale | 400 | $41k | 8.4% | Plan not stated | SEC |
| Aug 4, 2016 | Holzrichter Julie | Sr MD Chief Operating Officer | Form 4 sale | 2,425 | $250k | 7.4% | Plan not stated | SEC |
| Aug 2, 2016 | Sammann Derek | Sr MD Gl Hd Comm &Options Prod | Form 4 sale | 3,550 | $366k | 11.5% | Plan not stated | SEC |
| Aug 1, 2016 | Taylor Kimberly S | Sr MD Pres Gl Ops Tech & Risk | Form 4 sale | 2,300 | $236k | 2.2% | Plan not stated | SEC |
| Jul 29, 2016 | Suskind Dennis | Director | Form 4 sale | 1,000 | $103k | 8.3% | Plan not stated | SEC |
| Jul 29, 2016 | Sammann Derek | Sr MD Gl Hd Comm &Options Prod | Form 4 sale | 3,640 | $372k | 11.7% | Plan not stated | SEC |
| Jul 29, 2016 | Gepsman Martin J | Director | Form 4 sale | 500 | $51k | 1.1% | Plan not stated | SEC |
| Jul 15, 2016 | Oliff James E | Director | Form 4 sale | 1,000 | $102k | 2.7% | Plan not stated | SEC |
| Jun 30, 2016 | Taylor Kimberly S | Sr MD Pres Gl Ops Tech & Risk | Form 4 sale | 2,300 | $222k | 2.1% | Plan not stated | SEC |
| Jun 28, 2016 | Gill Phupinder | CEO | Form 4 sale | 31,120 | $2.9M | 18.8% | Plan not stated | SEC |
| Jun 13, 2016 | Kometer Kevin | Sr MD Chief InformationOfficer | Form 4 sale | 3,825 | $365k | 8.3% | Plan not stated | SEC |
| Jun 6, 2016 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 3,900 | $377k | 8.4% | Unusual | SEC |
| Jun 6, 2016 | Cronin Kathleen M | Sr MD Gen Counsel & Corp Secr | Form 4 sale | 6,200 | $600k | 20.1% | Unusual | SEC |
| Jun 3, 2016 | Zagotta Robert | Sr MD Strategy & Execution | Form 4 sale | 5,458 | $528k | 30.6% | Unusual | SEC |
| Jun 3, 2016 | Taylor Kimberly S | Sr MD Pres Gl Ops Tech & Risk | Form 4 sale | 7,400 | $713k | 6.4% | Unusual | SEC |
| May 31, 2016 | Taylor Kimberly S | Sr MD Pres Gl Ops Tech & Risk | Form 4 sale | 2,300 | $227k | 2.1% | Plan not stated | SEC |
| Apr 28, 2016 | Taylor Kimberly S | Sr MD Pres Gl Ops Tech & Risk | Form 4 sale | 2,300 | $213k | 2.0% | Plan not stated | SEC |
| Mar 30, 2016 | Taylor Kimberly S | Sr MD Pres Gl Ops Tech & Risk | Form 4 sale | 2,300 | $220k | 2.0% | Plan not stated | SEC |
| Mar 11, 2016 | Kometer Kevin | Sr MD Chief InformationOfficer | Form 4 sale | 500 | $47k | 1.3% | Plan not stated | SEC |
| Mar 9, 2016 | Duffy Terrence A | Executive Chairman & President | Form 4 sale | 15,340 | $1.4M | 16.6% | Plan not stated | SEC |
| Mar 4, 2016 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 252 | $24k | 1.1% | Plan not stated | SEC |
| Mar 1, 2016 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 500 | $46k | 1.3% | Plan not stated | SEC |
| Feb 26, 2016 | Pankau Ronald A. | Director | Form 4 sale | 200 | $19k | 5.1% | Plan not stated | SEC |
| Feb 22, 2016 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 1,145 | $108k | 4.8% | Plan not stated | SEC |
| Dec 3, 2015 | Zagotta Robert | Sr MD Strategy & Execution | Form 4 sale | 2,224 | $213k | 14.6% | Plan not stated | SEC |
| Nov 20, 2015 | Durkin Bryan T | Sr MD Chief Commercial Officer | Form 4 sale | 11,250 | $1.1M | 16.8% | Plan not stated | SEC |
| Oct 30, 2015 | Oliff James E | Director | Form 4 sale | 1,000 | $95k | 2.6% | Plan not stated | SEC |
| Sep 1, 2015 | Pankau Ronald A. | Director | Form 4 sale | 400 | $37k | 9.3% | Plan not stated | SEC |
| Aug 18, 2015 | Tobin Jack J | MD Chief Accounting Officer | Form 4 sale | 600 | $59k | 5.5% | Plan not stated | SEC |
| Aug 13, 2015 | Gepsman Martin J | Director | Form 4 sale | 700 | $68k | 1.6% | Plan not stated | SEC |
| Aug 3, 2015 | Gill Phupinder | CEO | Form 4 sale | 29,425 | $2.8M | 20.6% | Plan not stated | SEC |
| Aug 3, 2015 | Sammann Derek | Sr MD Commodity & Options Prod | Form 4 sale | 3,000 | $289k | 13.6% | Plan not stated | SEC |
| Jun 12, 2015 | Cronin Kathleen M | Sr MD Gen Counsel & Corp Secr | Form 4 sale | 6,500 | $640k | 26.9% | Unusual | SEC |
| Jun 3, 2015 | Cronin Kathleen M | Sr MD Gen Counsel & Corp Secr | Form 4 sale | 2,000 | $190k | 10.2% | Plan not stated | SEC |
| Jun 2, 2015 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 1,010 | $95k | 2.7% | Plan not stated | SEC |
| Jun 1, 2015 | Gill Phupinder | CEO | Form 4 sale | 5,000 | $470k | 3.9% | Plan not stated | SEC |
| May 29, 2015 | Duffy Terrence A | Executive Chairman & President | Form 4 sale | 29,496 | $2.8M | 26.8% | Unusual | SEC |
| May 27, 2015 | Kometer Kevin | Sr MD Chief InformationOfficer | Form 4 sale | 4,500 | $423k | 11.5% | Plan not stated | SEC |
| May 15, 2015 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 497 | $48k | 1.4% | Plan not stated | SEC |
| May 8, 2015 | Pankau Ronald A. | Director | Form 4 sale | 400 | $38k | 11.0% | Plan not stated | SEC |
| May 5, 2015 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 743 | $67k | 2.0% | Plan not stated | SEC |
| Apr 15, 2015 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 750 | $69k | 2.0% | Plan not stated | SEC |
| Apr 2, 2015 | Pietrowicz John W. | Sr MD Chief Financial Officer | Form 4 sale | 1,000 | $95k | 2.7% | Plan not stated | SEC |
| Mar 20, 2015 | Gill Phupinder | CEO | Form 4 sale | 30,000 | $3M | 19.6% | Plan not stated | SEC |
| Mar 16, 2015 | Harley Jill A | MD & CAO | Form 4 sale | 1,950 | $195k | 16.1% | Plan not stated | SEC |
| Mar 16, 2015 | Taylor Kimberly S | Sr MD Pres Gl Ops Tech & Risk | Form 4 sale | 13,000 | $1.3M | 11.4% | Plan not stated | SEC |
| Mar 3, 2015 | Gepsman Martin J | Director | Form 4 sale | 500 | $48k | 1.2% | Plan not stated | SEC |
| Feb 25, 2015 | Sammann Derek | Sr MD Commodity & Options Prod | Form 4 sale | 4,770 | $460k | 18.5% | Plan not stated | SEC |
| Feb 11, 2015 | Duffy Terrence A | Executive Chairman & President | Form 4 sale | 30,875 | $2.9M | 21.7% | Plan not stated | SEC |
| Feb 10, 2015 | Pankau Ronald A. | Director | Form 4 sale | 350 | $33k | 8.8% | Plan not stated | SEC |
| Feb 6, 2015 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 1,600 | $150k | 7.4% | Plan not stated | SEC |
| Feb 6, 2015 | Harley Jill A | MD & CAO | Form 4 sale | 800 | $76k | 7.2% | Plan not stated | SEC |
| Feb 5, 2015 | Harley Jill A | MD & CAO | Form 4 sale | 344 | $31k | 3.2% | Plan not stated | SEC |
| Jan 2, 2015 | Harley Jill A | MD& CAO | Form 4 sale | 350 | $31k | 3.2% | Plan not stated | SEC |
| Dec 19, 2014 | Harley Jill A | MD & CAO | Form 4 sale | 800 | $74k | 6.8% | Plan not stated | SEC |
| Dec 18, 2014 | Harley Jill A | MD & CAO | Form 4 sale | 800 | $72k | 6.8% | Plan not stated | SEC |
| Dec 12, 2014 | Harley Jill A | MD&CAO | Form 4 sale | 400 | $35k | 3.5% | Plan not stated | SEC |
| Dec 8, 2014 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 5,825 | $518k | 22.4% | Plan not stated | SEC |
| Nov 17, 2014 | Harley Jill A | MD & CAO | Form 4 sale | 450 | $38k | 3.8% | Plan not stated | SEC |
| Nov 14, 2014 | Gepsman Martin J | Director | Form 4 sale | 500 | $42k | 1.2% | Plan not stated | SEC |
| Nov 3, 2014 | Sammann Derek | Sr MD Commodities P&S | Form 4 sale | 10,000 | $843k | 30.3% | Unusual | SEC |
| Nov 3, 2014 | Duffy Terrence A | Executive Chairman & President | Form 4 sale | 14,580 | $1.2M | 11.6% | Plan not stated | SEC |
| Nov 3, 2014 | Cronin Kathleen M | Sr MD Gen Counsel & Corp Secr | Form 4 sale | 1,920 | $162k | 9.7% | Plan not stated | SEC |
| Oct 1, 2014 | Harley Jill A | MD & CAO | Form 4 sale | 1,200 | $96k | 9.1% | Plan not stated | SEC |
| Sep 15, 2014 | Harley Jill A | MD & CAO | Form 4 sale | 2,820 | $226k | 18.4% | Plan not stated | SEC |
| Sep 15, 2014 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 5,497 | $437k | 21.3% | Plan not stated | SEC |
| Sep 2, 2014 | Durkin Bryan T | COO | Form 4 sale | 25,625 | $2M | 35.3% | Unusual | SEC |
| Aug 13, 2014 | Pankau Ronald A. | Director | Form 4 sale | 400 | $29k | 9.8% | Plan not stated | SEC |
| Aug 1, 2014 | Gepsman Martin J | Director | Form 4 sale | 800 | $60k | 1.8% | Plan not stated | SEC |
| Jul 23, 2014 | Harley Jill A | MD & CAO | Form 4 sale | 2,710 | $203k | 20.1% | Plan not stated | SEC |
| Jul 23, 2014 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 2,282 | $171k | 10.8% | Plan not stated | SEC |
| Jun 2, 2014 | Gill Phupinder | CEO | Form 4 sale | 49,000 | $3.5M | 29.5% | Unusual | SEC |
| May 22, 2014 | Piell Hilda Harris | SR MD and Chief HR Officer | Form 4 sale | 4,730 | $331k | 18.3% | Plan not stated | SEC |
| May 21, 2014 | Odom C C II | Director | Form 4 sale | 2,000 | $139k | 99.9% | Unusual | SEC |
| Mar 6, 2014 | Gill Phupinder | CEO | Form 4 sale | 25,000 | $1.9M | 17.9% | Plan not stated | SEC |
| Feb 19, 2014 | Odom C C II | Director | Form 4 sale | 2,000 | $152k | 50.0% | Unusual | SEC |
| Feb 12, 2014 | Odom C C II | Director | Form 4 sale | 2,000 | $152k | 33.3% | Unusual | SEC |
| Feb 6, 2014 | Pankau Ronald A. | Director | Form 4 sale | 120 | $9k | 3.8% | Plan not stated | SEC |
| Feb 6, 2014 | Odom C C II | Director | Form 4 sale | 2,000 | $147k | 25.0% | Plan not stated | SEC |
| Dec 13, 2013 | Clegg Jackie M | Director | Form 4 sale | 2,000 | $162k | 21.8% | Plan not stated | SEC |
| Dec 10, 2013 | Cronin Kathleen M | Sr MD Gen Counsel & Corp Secr | Form 4 sale | 1,155 | $93k | 6.6% | Plan not stated | SEC |
| Dec 6, 2013 | Odom C C II | Director | Form 4 sale | 500 | $40k | 5.9% | Plan not stated | SEC |
| Nov 22, 2013 | Rich Linda Dallas | Sr MD Govt Rel Legisl Affairs | Form 4 sale | 3,861 | $323k | 32.4% | Unusual | SEC |
| Nov 21, 2013 | Duffy Terrence A | Executive Chairman & President | Form 4 sale | 22,525 | $1.9M | 18.5% | Plan not stated | SEC |
| Nov 19, 2013 | Odom C C II | Director | Form 4 sale | 1,532 | $123k | 15.3% | Plan not stated | SEC |
| Nov 18, 2013 | Gepsman Martin J | Director | Form 4 sale | 500 | $40k | 1.2% | Plan not stated | SEC |
| Nov 18, 2013 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 4,500 | $360k | 17.5% | Plan not stated | SEC |
| Nov 13, 2013 | Donaldson James A | Director | Form 4 sale | 1,200 | $94k | 5.6% | Plan not stated | SEC |
| Sep 16, 2013 | Pieper James V. | MD & CAO | Form 4 sale | 3,785 | $274k | 55.2% | Unusual | SEC |
| Sep 10, 2013 | Pankau Ronald A. | Director | Form 4 sale | 136 | $10k | 4.1% | Plan not stated | SEC |
| Sep 4, 2013 | Rich Linda Dallas | Sr MD Govt Rel Legisl Affairs | Form 4 sale | 1,737 | $126k | 20.1% | Plan not stated | SEC |
| Aug 29, 2013 | Pieper James V. | MD & CAO | Form 4 sale | 8,584 | $604k | 64.3% | Unusual | SEC |
| Aug 19, 2013 | Odom C C II | Director | Form 4 sale | 950 | $69k | 8.6% | Plan not stated | SEC |
| Aug 15, 2013 | Sammann Derek | Sr MD FX Metals & Options Sol | Form 4 sale | 10,530 | $787k | 36.8% | Unusual | SEC |
| Aug 14, 2013 | Sammann Derek | Sr MD FX Metals & Options Sol | Form 4 sale | 2,500 | $185k | 12.1% | Plan not stated | SEC |
| Jun 17, 2013 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 5,315 | $399k | 21.3% | Plan not stated | SEC |
| Jun 12, 2013 | Cronin Kathleen M | Sr MD Gen Counsel & Corp Secr | Form 4 sale | 3,135 | $228k | 16.6% | Plan not stated | SEC |
| Jun 5, 2013 | Pankau Ronald A. | Director | Form 4 sale | 370 | $26k | 13.5% | Plan not stated | SEC |
| May 30, 2013 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 2,100 | $147k | 9.6% | Plan not stated | SEC |
| May 28, 2013 | Parisi James E. | CFO & Sr MD Finance & Corp Dev | Form 4 sale | 37,000 | $2.4M | 43.6% | Unusual | SEC |
| May 20, 2013 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 2,600 | $168k | 11.7% | Plan not stated | SEC |
| May 6, 2013 | Gepsman Martin J | Director | Form 4 sale | 500 | $31k | 1.2% | Plan not stated | SEC |
| May 3, 2013 | Gill Phupinder | CEO | Form 4 sale | 43,500 | $2.6M | 28.7% | Unusual | SEC |
| Mar 14, 2013 | Duffy Terrence A | Executive Chairman & President | Form 4 sale | 39,710 | $2.5M | 29.9% | Unusual | SEC |
| Mar 12, 2013 | Odom C C II | Director | Form 4 sale | 2,243 | $140k | 18.3% | Plan not stated | SEC |
| Mar 12, 2013 | Vroman Ken | Sr MD Comm & Info Prod & Svcs | Form 4 sale | 1,492 | $94k | 6.5% | Plan not stated | SEC |
| Mar 11, 2013 | Kometer Kevin | Sr MD & CIO | Form 4 sale | 10,443 | $652k | 26.4% | Unusual | SEC |
| Feb 8, 2013 | Katler Gary M | Director | Form 4 sale | 290 | $16k | 22.5% | Plan not stated | SEC |
| Jan 17, 2013 | Rich Linda Dallas | Sr MD Govt Rel Legisl Affairs | Form 4 sale | 4,350 | $239k | 37.9% | Unusual | SEC |
| Dec 18, 2012 | Rich Linda Dallas | Sr MD Govt Rel Legisl Affairs | Form 4 sale | 1,593 | $82k | 18.3% | Plan not stated | SEC |
| Dec 12, 2012 | Piell Hilda Harris | Sr MD & Chief HR Officer | Form 4 sale | 2,857 | $152k | 13.5% | Plan not stated | SEC |
| Dec 7, 2012 | Parisi James E. | CFO & Sr MD Finance & Corp Dev | Form 4 sale | 1,912 | $105k | 3.7% | Plan not stated | SEC |
| Nov 19, 2012 | Katler Gary M | Director | Form 4 sale | 185 | $10k | 12.5% | Plan not stated | SEC |
| Nov 1, 2012 | Katler Gary M | Director | Form 4 sale | 530 | $30k | 26.4% | Unusual | SEC |
| Sep 14, 2012 | Paulhac Laurent | Sr MD Fincl & OTC Prod & Svcs | Form 4 sale | 3,585 | $214k | 24.3% | Plan not stated | SEC |
| Sep 13, 2012 | Cronin Kathleen M | Sr MD Gen Counsel & Corp Secr | Form 4 sale | 2,610 | $155k | 15.0% | Plan not stated | SEC |
| Sep 11, 2012 | Donaldson James A | Director | Form 4 sale | 7,500 | $437k | 27.0% | Unusual | SEC |
| Sep 11, 2012 | Odom C C II | Director | Form 4 sale | 5,000 | $292k | 29.0% | Unusual | SEC |
| Jul 30, 2012 | Katler Gary M | Director | Form 4 sale | 900 | $47k | 31.0% | Unusual | SEC |
| May 29, 2012 | Katler Gary M | Director | Form 4 sale | 38 | $10k | 11.2% | Plan not stated | SEC |
| Mar 7, 2012 | Taylor Kimberly S | President CME Clearing | Form 4 sale | 5,382 | $1.5M | 25.8% | Unusual | SEC |
| Mar 1, 2012 | Pietrowicz John W. | MD Business Dev & Corp Finance | Form 4 sale | 1,092 | $313k | 22.9% | Plan not stated | SEC |
| Feb 28, 2012 | Katler Gary M | Director | Form 4 sale | 170 | $50k | 33.5% | Unusual | SEC |
| Feb 22, 2012 | Carey Charles P | Director | Form 4 sale | 2,193 | $637k | 32.6% | Unusual | SEC |